BMY's growth-driving portfolio increased 17% year-over-year, prompting an upward revision in 2025 revenue guidance and ...
ProQR ( ($PRQR) ) has issued an announcement. On November 3, 2025, ProQR Therapeutics hosted a virtual analyst and investor event to discuss its ...
Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...
Demonstrated feasibility of effective DNA delivery with Company's xPhore nanoparticle technologyDNA delivery technology to be offered as GenePhore to biotech / pharma companiesAddressing large and gro ...
Novartis will acquire Avidity Biosciences for $12 billion at $72 per share, gaining its RNA-targeting platform and neuroscience pipeline as Avidity spins off its precision cardiology programs into a ...
The Brighterside of News on MSN
New molecule targets and destroys harmful RNA linked to cancer and aging
Within each cell, there is a constant struggle between life-sustaining molecules and molecules that could hasten its demise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback